Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients

Journal of Internal Medicine

Volumn 266, Issue 3, 2009, Pages 277-285

  Delaby, C ^b,c   To Figueras, J ^a,d   Deybach, J C ^b,c   Casamitjana, R ^d   Puy, H ^b,c   Herrero, C ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c HÔPITAL LOUIS MOURIER   (France)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Acute intermittent porphyria; Insulin like growth factor 1; Malnutrition; Transthyretin

Indexed keywords

HEME ARGINATE; LIVER PROTEIN; PORPHOBILINOGEN DEAMINASE; PREALBUMIN; SOMATOMEDIN C;

ABDOMINAL PAIN; ACUTE INTERMITTENT PORPHYRIA; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LIVER FUNCTION TEST; MALE; MALNUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MORBIDITY; PORPHYRIA, ACUTE INTERMITTENT; PREALBUMIN; STATISTICS, NONPARAMETRIC;

EID: 68949090452     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02118.x     Document Type: Article

References (27)

1. Nordmann Y., Puy H., Da Silva V et al. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. J Intern Med, 1997 242 : 213 7.
2. Thunell S., Harper P., Brock A., Petersen N.E. Porphyrins, porphyrin metabolism and porphyrias. II. Diagnosis and monitoring in the acute porphyrias. Scand J Clin Lab Invest, 2000 60 : 541 59.
3. Brennan M.J., Cantrill R.C., Kramer S. Effect of delta-aminolaevulinic acid on GABA receptor binding in synaptic plasma membranes. Int J Biochem, 1980 12 : 833 5.
4. Lindberg R.L., Porcher C., Grandchamp B et al. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet, 1996 12 : 195 9.
5. Thunell S. (Far) Outside the box: genomic approach to acute porphyria. Physiol Res, 2006 55 (Suppl. 2 S43 66.
6. Handschin C., Lin J., Rhee J et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell, 2005 122 : 505 15.
7. Soonawalla Z.F., Orug T., Badminton M.N et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet, 2004 363 : 705 6.
8. Fuhrman M.P., Charney P., Mueller C.M. Hepatic proteins and nutrition assessment. J Am Diet Assoc, 2004 104 : 1258 64.
9. Elder G.H., Hift R.J. Treatment of acute porphyria. Hosp Med, 2001 62 : 422 5.
10. To-Figueras J., Badenas C., Carrera C et al. Genetic and biochemical characterization of 16 acute intermittent porphyria cases with a high prevalence of the R173W mutation. J Inherit Metab Dis, 2006 29 : 580 5.
11. Gouya L., Puy H., Robreau A.M et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet, 2004 114 : 256 62.
12. Puy H., Deybach J.C., Lamoril J et al. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet, 1997 60 : 1373 83.
13. Puy H., Gross U., Deybach J.C et al. Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria. Hum Genet, 1998 103 : 570 5.
14. Granada M.L., Ulied A., Casanueva F.F et al. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clin Endocrinol (Oxf), 2008 68 : 942 50.
15. Lim C.K., Peters T.J. Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta, 1984 139 : 55 63.
16. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev, 1995 16 : 3 34.
17. Bernstein L.H., Ingenbleek Y. Transthyretin: its response to malnutrition and stress injury. Clinical usefulness and economic implications. Clin Chem Lab Med, 2002 40 : 1344 8.
18. Yakar S., Liu J.L., Stannard B et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA, 1999 96 : 7324 9.
19. Yamamoto H., Sohmiya M., Oka N., Kato Y. Effects of aging and sex on plasma insulin-like growth factor I (IGF-I) levels in normal adults. Acta Endocrinol (Copenh), 1991 124 : 497 500.
20. Clemmons D.R., Van Wyk J.J. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab, 1984 13 : 113 43.
21. Clemmons D.R., Underwood L.E., Dickerson R.N et al. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Clin Nutr, 1985 41 : 191 8.
22. Argente J., Caballo N., Barrios V et al. Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. Horm Res, 1997 48 (Suppl. 4 16 8.
23. Caregaro L., Favaro A., Santonastaso P et al. Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. Clin Nutr, 2001 20 : 251 7.
24. Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev, 2003 24 : 78 90.
25. Puigserver P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond), 2005 29 (Suppl. 1 S5 9.
26. Johnson A.M. Low levels of plasma proteins: malnutrition or inflammation? Clin Chem Lab Med, 1999 37 : 91 6.
27. Clark M.A., Hentzen B.T., Plank L.D., Hill G.I. Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury. JPEN J Parenter Enteral Nutr, 1996 20 : 363 70.